About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

UVA Light Device to Treat COVID-19 | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT04572399

UVA Light Device to Treat COVID-19

This pilot study will assess the safety and effectiveness of UV light treatment in hospitalized patients with COVID-19.

Lead sponsor: Cedars-Sinai Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Cedars-Sinai Medical Center

Collaborators

Aytu BioPharma, Inc.

This is a single center, open label, pilot study. 5 adult patients, aged over 18, who are confirmed positive with SARS-CoV-2 and are newly intubed, will receive UV light treatment to reduce SARS-CoV-2 viral load.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Confirmed positive test result for SARS-CoV-2
•Mechanically ventilated
•Endotracheal tube inner diameter of at least 7.5 mm

Exclusion Criteria

•Unable to provide informed consent (or surrogate)
•Enrolled in a therapeutic clinical trial for same condition that does not allow recruitment in other trials
•Pregnant women

Related studies

RECRUITINGPhase 1

A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir

NCT07552779 · Coronavirus Disease 2019, Coronavirus Disease 2019 (COVID-19), and more

RECRUITINGPhase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more

Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health

NCT04573062 · Post-Coronavirus Disease 19

Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors

NCT05164744 · COVID-19 Pneumonia, COVID-19, and more

In-depth Immunological Investigation of COVID-19.

NCT04327570 · Coronavirus Infections

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 9, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment5

Start dateOct 2020

Last updatedJan 9, 2025

Condition

Locations shown

Cedars-Sinai Medical Center

Los Angeles, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 9, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions